NCT02098642

Brief Summary

Parkinson's disease is a degenerative disorder of the central nervous system. The motor symptoms of Parkinson's disease result from the death of dopamine-generating cells in the substantia nigra, a region of the midbrain; the cause of this cell death is unknown. Early in the course of the disease, the most obvious symptoms are movement-related; these include shaking, rigidity, slowness of movement and difficulty with walking and gait. A multidisciplinary intensive rehabilitation treatment (MIRT) is able to improve different parameters in PD that are poorly responsive to dopaminergic therapy. In this study, we aim to understand whether the passive mobilization of the metatarsophalangeal joint of the hallux determines an increase in the joint range in this district, allowing to improve, at least, the gait.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 21, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 28, 2014

Completed
Last Updated

March 28, 2014

Status Verified

March 1, 2014

Enrollment Period

8 months

First QC Date

March 21, 2014

Last Update Submit

March 24, 2014

Conditions

Keywords

Gait DisturbancesMetatarsophalangeal joint

Outcome Measures

Primary Outcomes (1)

  • FOGQ

    Freezing of Gait Questionnaire Value

    One month

Secondary Outcomes (3)

  • UPDRS III

    One month

  • BBS

    One month

  • Hallux

    One month

Study Arms (2)

Patients with passive joint mobilization

Patients diagnosed with PD according to the Gelb et al in Hoen\&Yahr stage 3, with Freezing of Gait and treated with a Multidisciplinary intensive rehabilitation treatment (MIRT), including the mobilization of the metatarsophalangeal joint of the hallux

Other: MIRTOther: Mobilization of the metatarsophalangeal joint of the hallux

No passive joint mobilization

Patients diagnosed with PD according to the Gelb et al in Hoen\&Yahr stage 3, with Freezing of Gait and treated with a Multidisciplinary intensive rehabilitation treatment (MIRT)

Other: MIRT

Interventions

MIRTOTHER

A 4-week cycle of physiotherapy that entailed three daily sessions, 5 days a week. The first session comprised cardiovascular warm-up activities, relaxation exercises, muscle-stretching, exercises to improve the range of motion of spinal, pelvic and scapular joints, and exercises to improve the functionality of abdominal muscles and postural changes in the supine position. The second session included exercises to improve balance and gait using a stabilometric platform with a visual cue and treadmill training associated with auditory and visual cues (treadmill plus). The last was an occupational therapy session with the aim of improving autonomy in daily living activities.

No passive joint mobilizationPatients with passive joint mobilization

MIRT and mobilization of the metatarsophalangeal joint of the hallux

Patients with passive joint mobilization

Eligibility Criteria

Age49 Years - 88 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

PD

You may qualify if:

  • PD patients stage 3 H\&Y with FOG

You may not qualify if:

  • we excluded patients with atypical parkinsonism, with other concomitant neurological conditions (with cerebrovascular etc.), with joint disorders, muscle disorders or with other orthopedic conditions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Parkinson's Disease and Movement Disorders Rehabilitation Unit

Gravedona, Como, 22015, Italy

Location

MeSH Terms

Conditions

Parkinson DiseaseMobility Limitation

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Giuseppe Frazzitta, MD

    Ospedale Generale Di Zona Moriggia-Pelascini

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2014

First Posted

March 28, 2014

Study Start

March 1, 2013

Primary Completion

November 1, 2013

Study Completion

February 1, 2014

Last Updated

March 28, 2014

Record last verified: 2014-03

Locations